Ceribell for Efficient Expansion of Acute Care Neurodiagnostics Ceribell empowers neurologists to expand EEG coverage in any hospital department without the need for additional EEG systems or staff With Ceribell,…
Search Results
Not what you’re looking for? Search again
Clinical Studies
Clinical Data and Supporting Evidence The Ceribell Point-of-Care EEG system has been clinically demonstrated to empower physicians to make faster, more accurate diagnostic decisions for informed treatment plans Impact/Accuracy Utility…
DECIDE Study
Clinical Data and Supporting Evidence: DECIDE Study Ceribell Rapid Response EEG was demonstrated to significantly improve clinical accuracy Results from the DECIDE study (a prospective, multi-center clinical trial to assess…
Clarity Study
Clinical Data and Supporting Evidence: Clarity™ Study ClarityPro has been validated to consistently alert for suspected status epilepticus and rule out seizures Ceribell with Clarity was demonstrated to differentiate EEGs…
NCSE
The Challenge of Non-Convulsive Seizures Non-convulsive seizures are a neurological emergency that needs to be treated quickly to prevent brain damage. An electroencephalogram (EEG) is required to detect these seizures,…
Company
About Us Ceribell, Inc., the developer of the first AI-powered point-of-care EEG diagnostic system, is revolutionizing seizure management in acute care. Ceribell’s mission is to make EEG diagnostics widely available,…